Journal of Pediatric Psychology 18(6) pp. 717-730, 1993
© 1993 Society of Pediatric Psychology
research-article |
Methods of Evaluating Methylphenidate in Children with Attention Deficit Hyperactivity Disorder: Acceptability, Satisfaction, and Compliance1
University of British Columbia
2All correspondence should be sent to Charlotte Johnston, Department of Psychology, University of British Columbia, Vancouver, British Columbia, V6T 1Z4, Canada
Compared two methods of evaluating methylphenidate (MPH) on measures of parental acceptance, satisfaction, and compliance with the treatment. Twenty-four 6- to 10-year-old children with Attention Deficit Hyperactivity Disorder (ADHD) were randomly assigned to either a blind, placebo-controlled medication trial (MT) or to a typical clinical procedures (TCP) evaluation that was nonblind and without a placebo control. Ratings of satisfaction were significantly higher in the MT condition than in the TCP condition; however, all parents became more accepting of MPH after participating in an evaluation. Both during the evaluation and at 6-week and 3-month follow-ups, approximately 20% of cases were not complying with treatment. However, rates of compliance did not differ between the MT and TCP conditions.
Key words: methylpbenidate; treatment acceptability; consumer satisfaction; treatment compliance.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. V. Faraone, J. Biederman, and B. Zimmerman An Analysis of Patient Adherence to Treatment During a 1-Year, Open-label Study of OROS(R) Methylphenidate in Children With ADHD J Atten Disord, September 1, 2007; 11(2): 157 - 166. [Abstract] [PDF] |
||||
![]() |
L. K. Leslie, J. Weckerly, D. Plemmons, J. Landsverk, and S. Eastman Implementing the American Academy of Pediatrics Attention-Deficit/Hyperactivity Disorder Diagnostic Guidelines in Primary Care Settings Pediatrics, July 1, 2004; 114(1): 129 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Ohan and C. Johnston Reported Rates of Adherence to Medication Prescribed for Adolescents' Symptoms of ADHD Clinical Child Psychology and Psychiatry, October 1, 2000; 5(4): 581 - 593. [Abstract] [PDF] |
||||
![]() |
M. A. Kent, C. S. Camfield, and P. R. Camfield Double-blind Methylphenidate Trials: Practical, Useful, and Highly Endorsed by Families Arch Pediatr Adolesc Med, December 1, 1999; 153(12): 1292 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Hale, J.-A. B. Hoeppner, M. B. DeWitt, D. L. Coury, D. G. Ritacco, and B. Trommer Evaluating Medication Response in ADHD: Cognitive, Behavioral, and Single-Subject Methodology J Learn Disabil, November 1, 1998; 31(6): 595 - 607. [Abstract] [PDF] |
||||
![]() |
H. N. Bawden, G. W. MacDonald, and S. Shea Treatment of Children With Williams Syndrome With Methylphenidate J Child Neurol, June 1, 1997; 12(4): 248 - 252. [Abstract] [PDF] |
||||





